阿尔茨海默病缩的数据驱动子类型有多可复制?
1Department of Medical Physics and Biomedical Engineering, University College London, Gower Street, London, UK.
Journal of Alzheimer's disease : JAD
|January 28, 2026
概括
这项研究使用SuStaIn算法在各种数据集中验证了阿尔茨海默病 (AD) 亚型. 结果证实了亚型的稳定性,但强调了在研究队伍中需要更大的种族多样性.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 呈现出显著的临床和生物异质性,具有挑战性的治疗开发.
- 计算方法为AD亚型和分期提供了洞察力,但跨数据集的亚型可重现性尚未得到研究.
研究的目的:
- 评估由亚型和阶段推断 (SuStaIn) 算法识别的阿尔茨海默病进展亚型的稳定性.
- 在更大,更多样化的队列中验证这些亚型,评估它们在不同数据集和队列组成中的稳定性.
主要方法:
- 利用来自ANMerge,OASIS和ADNI数据集的544名受试者的T1加权MRI数据,形成四个独立的队列.
- 应用了SuStaIn算法来分析每个队列,测试子类型的强度,包括或不包括认知正常的对照.
主要成果:
- 证实了三种主要缩亚型:典型,皮层和皮下,以及像后皮层缩这样的罕见变体.
- 证明了不同亚型的强度来控制纳入,其中皮质下亚型对队列组成的敏感性更高.
结论:
- 亚型和阶段推断 (SuStaIn) 算法可靠地定义了稳定的阿尔茨海默病亚型,支持其在临床分层中用于试验和诊断.
- 强调在数据集中加强种族和人口多样性的关键需求,以提高AD亚型研究的概括性和临床适用性.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


